Introduction
============

Rapid progression of medical knowledge has allowed investigators to address many gaps in cardiac sciences^[@bib1]--[@bib2]^ through improving cardiac care provided and achieving higher standards of management.^[@bib3]--[@bib6]^ Targeted medical therapies and focused care reduced major adverse cardiac event rates in the last decade.^[@bib7]--[@bib10]^ As a result, global life expectancy has increased significantly, and the number of elderly patients in need of cardiac care increased dramatically.^[@bib3]^ However, these elderly patients are underrepresented in the vast majority of recent cohort studies and randomized clinical trials. Many were excluded because of significant physical and cognitive disability as well as associated comorbidities.^[@bib11]--[@bib12]^

Frailty assessment is often a difficult task.^[@bib13]^ Multiple assessment tools are used to assess the physical, social, and psychological status of this population.^[@bib14]--[@bib15]^ However, frailty prevalence is influenced by developmental and financial factors of nations,^[@bib16]--[@bib17]^ which might affect its distribution based upon variations in cardiovascular risk factors.^[@bib14]^ Additionally, frailty evaluation and quantification is a complex task that is only partially related to conventional coronary artery risk assessment. However, frailty has a significant impact on therapeutic clinical decisions in coronary artery disease.^[@bib18]--[@bib19]^

Saudi Arabia, as a developing country, stated a goal to increase its life expectancy by 5 years within the coming decade.^[@bib20]^ As the population ages, the prevalence of frailty and comorbid conditions, including coronary artery disease and other cardiac pathologies, are expected to increase. Therefore, identifying tools and resources that efficiently detect frailty among Saudi elderly patients is important. Thus, this study aims to describe the prevalence and predictors of frailty among Saudi patients referred for cardiac stress testing with nuclear imaging.

Methods
=======

Data collection and patients characteristics
--------------------------------------------

This is a cross-sectional study that included all consecutive patients who underwent a clinically indicated cardiac positron emission tomography (PET) at a tertiary care center between January and October 2016. This center provides advanced cardiovascular care, including advanced imaging techniques for cardiac patients.^[@bib21]^ Prior to the cardiac PET assessment, patients' baseline characteristics, cardiovascular risk factors, laboratory results, and medications used were collected. Patients were excluded if he or she refused to be enrolled in the study.

Frailty assessment and evaluation
---------------------------------

The frailty assessment was completed at the time of the PET procedure by a trained nurse using the Canadian Study of Health and Ageing Clinical Frailty Scale or in short "Fried Scale."^[@bib22]^ This scale is a semi-objective scale describing patients' frailty status according to quick and direct questions about patients' activities of daily living (ADLs) and interaction with surroundings. Patients were asked about their life dependence, need for assistance on any ADLs, instrumental ADLs, outside home activity, frequency of exercise, and current medical problems. Then, their level of frailty was established ([Figure 1](#fig1){ref-type="fig"}). Demented and terminally ill patients were excluded. Patients were considered to be frail if they had a score of four or higher on the Fried scale.

Study definitions
-----------------

Patients using antihyperglycemic medications or with a prior history of diabetes were reported as diabetics. Hypertension was defined as prior hypertension history or the use of any blood pressure-lowering medications. Patients with a prior diagnosis of lipid abnormality or using lipid-lowering therapies were considered to have dyslipidemia.

Statistical analysis
--------------------

Continuous data were presented as mean with standard deviation and categorical data as percent frequencies. Students' *t*-test and chi-square or Fisher\'s exact tests were used for group comparison, as appropriate. Multivariate logistic regression models were used to predict frail patients. The regression model consisted of patients' baseline characteristics, conventional cardiovascular risk factors, and cardiac-related medications. All analyses were conducted using Stata 14 software (StataCorp. 2015. *Stata Statistical Software: Release 14*. College Station, TX: StataCorp LP).^[@bib23]^ Statistical significance was considered if *p* ≤ 0.05.

Results
=======

A total of 876 patients (mean age 60.3 ± 11 years; 48.3% were women) were included. The prevalence of frailty was 40%. The prevalence of conventional cardiovascular risk factors including hypertension, diabetes, dyslipidemia, and smoking were 76%, 66%, 46%, and 9.6%, respectively. Many patients had a previous cardiac history: stroke 4.1%, percutaneous coronary intervention 18.4%, coronary artery bypass grafting 8.9%, and chronic heart failure 4.8%. Cardiac-related medications and angiotensin-related medications were used in every other patient, while beta-blockers and calcium channel blockers were used in one-third of the study cohort, and a quarter of the cohort were using diuretics ([Table 1](#tbl1){ref-type="table"}).

Frail patients were older, more often women, and had a higher body mass index ([Table 1](#tbl1){ref-type="table"}). In addition, they had a higher prevalence of hypertension (85.1% vs. 69.6%; *p* \< 0.001), diabetes (74.6% vs. 59.5%; *p* \< 0.001), previous stroke (5.7% vs. 3.0%; *p* = 0.051), and chronic kidney disease (6.3% vs. 3.8%; *p* = 0.023). They were more often on beta-blockers, angiotensin-converting enzymes, and diuretics ([Table 1](#tbl1){ref-type="table"}). Furthermore, frailty prevalence increased with increasing age across male and female groups ([Figure 2](#fig2){ref-type="fig"}). Surprisingly, patients younger than 60 years old had a high prevalence of frailty. Every other female patient older than the sixth decade was frail, and almost one-third of male patients in the same age group were frail, too.

Using a multivariate logistic regression model within the study cohort, we found that age, female gender, body mass index, diabetes, renal disease, and diuretics use were independently predictive of frail patients ([Table 2](#tbl2){ref-type="table"}).

Subgroup analysis for patients 65 years and older
-------------------------------------------------

Since frailty impacts clinical decisions mainly in older patients, we analyzed the older cohort separately. Among patients older than 65 years, frail patients were older (72 vs. 70 years, *p* \< 0.001), more often women (53% vs. 30%, *p* \< 0.001), and with higher body mass index (32.1 vs. 29.6 kg/m^2^, *p* \< 0.001). Despite that, no apparent differences between frail and nonfrail patients in cardiovascular risk factors and cardiac-related medications were noted ([Table 3](#tbl3){ref-type="table"}). A multivariate logistics regression model was used to define possible frailty predictors in this subgroup. Patients' age, gender, and body mass index were independently associated with frailty ([Table 4](#tbl4){ref-type="table"}).

Discussion
==========

Our study described the frailty prevalence in Saudi Arabia among patients who were referred for cardiac risk assessment by nuclear stress testing. Furthermore, we identified the predictors of elderly frail patients.^[@bib24]--[@bib26]^

Frailty assessment tools are numerous, and most of these are time consuming, which might have limited acceptance in a busy daily clinical practice. The Canadian Study of Health and Aging clinical frailty scale or in short Fried scale has been shown to have good diagnostic and prognostic values.^[@bib9],[@bib22]^ It was developed over 25 years ago^[@bib15],[@bib24],[@bib27]^ and was essential to describe the epidemiology of cognitive impairment and other important clinical factors among this target population.

The frailty prevalence in our study cohort was 40%, which is a little higher than other international published reports.^[@bib14],[@bib28]--[@bib29]^ Few published literature have stated that frailty is not a geriatric-related problem. Some younger patients could be frail while they are chronologically young. Results from our study population come in agreement with the previous observation. One could argue that frail patients younger than 65 years share some phenotypical characteristics with older frail patients. The impacts of these findings on management decisions and outcomes of these young frail patients warrant further study.

In addition, the heterogeneity of aging was seen in our study. Many elderly patients are not frail despite advanced chronological age. Van Kan et al.,^[@bib15]^ suggested that frailty is a predisability stage. This implies that disability is not the cause but rather a consequence of frailty. Disability should not be included in the definition nor used as a tool for the assessment.^[@bib15],[@bib30]^ Thus, frailty is considered to be a separate pathophysiological condition that has its own predisposing factors.

On the other hand, cardiovascular risk predictors are essential for clinical decision making and assessment for better patients' outcomes. Identifying patients who may benefit from any cardiac-specific treatments such as major procedures and critical interventions is the pillar for survival improvement and better quality of life.^[@bib31]--[@bib32]^ Despite that, traditional cardiac risk scores have their own limits. All these scores comprehend age as the main contributor without discrimination between actual and biological ages. Additionally, the generalizability of these risk scores is restricted since they always have an upper age limit. Thus, using simple frailty tools to assist in the prediction of major cardiac events might improve the predictability of coronary artery disease, management decisions, resource utilization, and hard outcomes.^[@bib23],[@bib33]--[@bib34]^ One should note that congestive heart failure and chronic kidney disease were associated with frailty status. This suggests that frailty is a clinical condition that can be detected across the spectrum of cardiovascular diseases.

Limitations
-----------

This study has several limitations. Although the clinical frailty scale is easy to implement, it has some subjective aspects that are predisposed to interobserver variability. Also, there might be an inherent selection bias. Patients with life-limiting diseases such as stroke, cancer, and end-stage renal failure have a short life expectancy. Thus, these conditions were not noted as predictors of frailty. Lastly, we did not assess the prognostic impacts of frailty on major cardiac events such as cardiac mortality, hospitalization, and revascularization.

Conclusions
===========

With the aging of the Saudi population, frailty prevalence is expected to increase. Elderly, obesity, hypertension, and female gender are risk factors to develop frailty. Interventions to reduce frailty should be focused on this high-risk population.
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###### 

Baseline characteristics of the study cohort.

                                     Overall population (n = 876)   Frailty status                   
  ---------------------------------- ------------------------------ ---------------- --------------- -----------
  Age (years)                        60.28 ± 11.45                  57.04 ± 11.09    65.14 ± 10.22    \< 0.001
                                                                                                     
  Female                             423 (48.29%)                   41.25%           58.86%          0.002
                                                                                                     
  Height (cm)                        161.29 ± 9.76                  163.43 ± 9.38    158.22 ± 9.49    \< 0.001
                                                                                                     
  Weight (kg)                        83.32 ± 17.72                  83.45 ± 17.15    83.15 ± 18.55   0.851
                                                                                                     
  BMI (kg/m^2^)                      31.81 ± 7.14                   30.91 ± 6.40     33.18 ± 7.94     \< 0.001
                                                                                                     
  Cardiovascular risk factor                                                                         
                                                                                                     
   Hypertension                      664 (75.80%)                   69.58%           85.14%           \< 0.001
                                                                                                     
   Diabetes                          574 (65.53%)                   59.51%           74.57%           \< 0.001
                                                                                                     
   Dyslipidaemia                     405 (46.23%)                   46.39%           46.00%          0.910
                                                                                                     
   Asthma                            74 (8.45%)                     7.03%            10.57%          0.065
                                                                                                     
   Smoking                           84 (9.59%)                     10.84%           7.71%           0.124
                                                                                                     
   Previous TIA/stroke               36 (4.11%)                     3.04%            5.71%           0.051
                                                                                                     
   Chronic renal failure             133 (15.18%)                   12.93%           18.57%          0.023
                                                                                                     
   Chronic heart failure             42 (4.79%)                     3.80%            6.29%           0.092
                                                                                                     
   Previous PCI                      161 (18.38%)                   19.58%           16.57%          0.260
                                                                                                     
   Previous CABG                     78 (8.90%)                     8.56%            9.43%           0.657
                                                                                                     
  Medications                                                                                        
                                                                                                     
   Angiotensin-related medications   469 (53.54%)                   50.57%           58.00%          0.031
                                                                                                     
   Beta blockers                     391 (44.63%)                   42.40%           48.00%          0.102
                                                                                                     
   Calcium channel blockers          294 (33.56%)                   30.42%           38.29%          0.016
                                                                                                     
   Diuretics                         219 (25.00%)                   18.44%           34.86%           \< 0.001
                                                                                                     

BMI, body mass index; TIA, transient ischemic attack; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting.

All the data were presented as frequencies or mean ( ± standard deviation), as appropriate. Chi-square test and student\'s t-test were used as indicated.

###### 

Multivariate logistic regression predict frail patients among study cohort.

                    Odds ratio   *p*         95% confidence interval
  ----------------- ------------ ----------- -------------------------
  Age               1.09          \< 0.001   (1.08--1.11)
                                             
  Female            2.19          \< 0.001   (1.56--3.08)
                                             
  Body mass index   1.05          \< 0.001   (1.03--1.08)
                                             
  Diabetes          1.57         0.011       (1.11--2.22)
                                             
  Renal disease     3.09          \< 0.001   (1.90--5.03)
                                             
  Diuretics         1.57         0.017       (1.08--2.27)
                                             

The model consists of baseline characteristics (age, gender \[female\], and body mass index), cardiac risk factors (hypertension, diabetes, stroke, and kidney disease), and medications (angiotensin-related medications, calcium channel blockers, and diuretics).

###### 

Baseline characteristics for subgroup (65 years and older).

  --------------------------------------------------------------------------------------------------------
                               Overall population (n = 332)   Frailty status                   
  ---------------------------- ------------------------------ ---------------- --------------- -----------
  Age (years)                  71.34 ± 5.42                   70.15 ± 4.54     72.16 ± 5.82     \< 0.001

                                                                                               

  Female                       144 (43.37%)                   29.63%           52.79%           \< 0.001

                                                                                               

  Height (cm)                  160.55 ± 9.22                  163.65 ± 7.59    158.68 ± 9.63    \< 0.001

                                                                                               

  Weight (kg)                  79.74 ± 15.60                  78.68 ± 13.91    80.38 ± 16.55   0.453

                                                                                               

  BMI (kg/m^2^)                31.06 ± 6.35                   29.60 ± 5.16     32.06 ± 6.88     \< 0.001

                                                                                               

  Cardiovascular risk factor                                                                   

                                                                                               

   Hypertension                275 (82.83%)                   80.00%           84.77%          0.257

                                                                                               

   Diabetes                    237 (71.39%)                   67.41%           74.11%          0.184

                                                                                               

   Dyslipidaemia               166 (50.00%)                   52.59%           48.22%          0.434

                                                                                               

   Asthma                      29 (8.73%)                     8.15%            9.14%           0.754

                                                                                               

   Smoking                     27 (8.13%)                     5.19%            10.15%          0.104

                                                                                               

   Previous TIA/stroke         17 (5.12%)                     2.96%            6.60%           0.140

                                                                                               

   Chronic renal failure       45 (13.55%)                    12.59%           14.21%          0.672

                                                                                               

   Chronic heart failure       17 (5.12%)                     5.19%            5.08%           0.965

                                                                                               

   Previous PCI                62 (18.67%)                    19.26%           18.27%          0.821

                                                                                               

   Previous CABG               45 (13.55%)                    15.56%           12.18%          0.378

                                                                                               

  Medications                                                                                  

                                                                                               

   Angiotensin-related\        199 (59.94%)                   59.26%           60.41%          0.834
  medications                                                                                  

                                                                                               

   Beta blockers               165 (49.70%)                   52.59%           47.72%          0.383

                                                                                               

   Calcium channel blockers    141 (42.47%)                   41.48%           43.15%          0.763

                                                                                               

   Diuretics                   100 (30.12%)                   25.93%           32.99%          0.168

                                                                                               
  --------------------------------------------------------------------------------------------------------

BMI, body mass index; TIA, transient ischemic attack; PCI: percutaneous coronary intervention; CABG, coronary artery bypass grafting.

All the data were presented as frequencies or mean ( ± standard deviation), as appropriate. Chi-square test and student\'s *t*-test were used as indicated.

###### 

Multivariate logistic regression predict frail patients older than 65 years.

                    Odds ratio   *p*         95% confidence interval
  ----------------- ------------ ----------- -------------------------
  Age               1.12          \< 0.001   (1.05--1.20)
                                             
  Female            2.64          \< 0.001   (1.30--5.45)
                                             
  Body mass index   1.06         0.017       (1.01--1.16)
                                             

The model consists of baseline characteristics (age, gender \[female\], and body mass index), cardiac risk factors (hypertension, diabetes, stroke, and kidney disease), and medications (angiotensin-related medications, calcium channel blockers, and diuretics).
